FDA Stops Being Antisocial - Recent Social Media Guidance Breaks the Silence

On January 13, FDA released long-awaited guidance on using social media to promote prescription drugs.  The guidance outlines FDA’s expectations for when and how a company should submit such “interactive promotional media” to the agency pursuant to postmarketing submission requirements.

During this 1-hour complimentary webinar, AGG's Food and Drug Practice leader, Alan Minsk, and associate, Kelley Nduom,  addressed questions such as:

  • Who influences or controls the message?
  • When should I submit a 2253?
  • Am I responsible if someone comments on our website?
  • What do we need to do differently?


 If you have previously registered for this event, please login below:

Registration is required to attend this event. Please register now.
First Name*
Last Name*
You must have Javascript and Cookies enabled to access this webcast. Click here for Help.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.